|
Agios Pharmaceuticals Inc.
|
|
|
|
|
|
Alexion, AstraZeneca Rare Disease
|
|
|
|
|
|
Amgen
|
|
|
|
|
|
Amgen Oncology
|
|
|
|
|
|
ASCO
|
|
|
|
|
|
ASCO
|
|
|
|
|
|
Astellas
|
|
|
|
|
|
AstraZeneca
|
|
|
|
|
|
AVEO Oncology, an LG Chem company
|
|
|
|
|
|
Boehringer Ingelheim
|
|
|
|
|
|
Bristol Myers Squibb
|
|
|
|
|
|
Daiichi Sankyo, Inc.
|
|
|
|
|
|
Daiichi Sankyo, Inc.
|
|
|
|
|
|
Eisai Inc
|
|
|
|
|
|
Elevar Therapeutics
|
|
|
|
|
|
Eli Lilly and Company
|
|
|
|
|
|
EMD Serono
|
|
|
|
|
|
Exact Sciences
|
|
|
|
|
|
Exelixis
|
|
|
|
|
|
Foundation Medicine
|
|
|
|
|
|
Geron Corporation
|
|
|
|
|
|
Gilead Sciences
|
|
|
|
|
|
GSK
|
|
|
|
|
|
Guardant Health
|
|
|
|
|
|
Hologic Oncology
|
|
|
|
|
|
Immunocore
|
|
|
|
|
|
Incyte
|
|
|
|
|
|
Iovance Biotherapeutics
|
|
|
|
|
|
Jazz Pharmaceuticals, Inc.
|
|
|
|
|
|
Merck & Co., Inc.
|
|
|
|
|
|
Natera
|
|
|
|
|
|
NMDP
|
|
|
|
|
|
Novartis
|
|
|
|
|
|
Novartis Pharmaceuticals USA
|
|
|
|
|
|
Parexel
|
|
|
|
|
|
Pfizer Oncology
|
|
|
|
|
|
Pfizer Oncology
|
|
|
|
|
|
Pharmacyclics LLC, an AbbVie Company
|
|
|
|
|
|
Regeneron
|
|
|
|
|
|
Rigel Pharmaceuticals
|
|
|
|
|